Pharmacological and therapeutic effects of Berberis vulgaris and its active constituent, berberine
Identifieur interne : 001976 ( Main/Exploration ); précédent : 001975; suivant : 001977Pharmacological and therapeutic effects of Berberis vulgaris and its active constituent, berberine
Auteurs : Mohsen Imanshahidi [Iran] ; Hossein Hosseinzadeh [Iran]Source :
- Phytotherapy Research [ 0951-418X ] ; 2008-08.
English descriptors
- Teeft :
- Alkaloid, Antimicrobial, Antiplatelet, Aortic, Aureus, Barberry, Berberine, Berberine chloride, Berberis, Berberis vulgaris, Bilirubin, Cardiac, Coli, Congestive heart failure, Copyright, Cyclosporine, Decoction, Escherichia, Hepatic, Hosseinzadeh, Huang, Hypotensive, Imanshahidi, Inhibitory effect, Inhibitory effects, Iran, Isoquinoline, Isoquinoline alkaloids, Ivanovska, John wiley sons, Mrna, Napalert, Peng, Pharm, Pharmacol, Pharmacological effects, Philipov, Phytother, Platelet, Protective effects, Rabbani, Receptor, Toxicity, Ventricular, Vulgaris, Wang, Zeng, Zhou.
Abstract
Barberry (Berberis vulgaris L. family Berberidaceae) is well known in Iran and various parts of this plant including its root, bark, leaf and fruit have been used as folk medicine. The two decades of research has demonstrated different pharmacological and therapeutic effects of B. vulgaris and its isoquinoline alkaloids (particularly berberine). Studies carried out on the chemical composition of the plant show that the most important constituents of this plant are isoquinoline alkaloids such as berberine, berbamine and palmatine. Berberine represents one of the most studied among the naturally occurring protoberberine alkaloids. In addition to B. vulgaris (barberry), berberine is present in many other plants and is used for the treatment of different diseases. This article reviews the traditional uses and pharmacological effects of total extract and the most active ingredient of B. vulgaris (berberine). Copyright © 2008 John Wiley & Sons, Ltd.
Url:
DOI: 10.1002/ptr.2399
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 002C81
- to stream Istex, to step Curation: 002C81
- to stream Istex, to step Checkpoint: 000881
- to stream Main, to step Merge: 001984
- to stream Main, to step Curation: 001976
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Pharmacological and therapeutic effects of Berberis vulgaris and its active constituent, berberine</title><author><name sortKey="Imanshahidi, Mohsen" sort="Imanshahidi, Mohsen" uniqKey="Imanshahidi M" first="Mohsen" last="Imanshahidi">Mohsen Imanshahidi</name></author><author><name sortKey="Hosseinzadeh, Hossein" sort="Hosseinzadeh, Hossein" uniqKey="Hosseinzadeh H" first="Hossein" last="Hosseinzadeh">Hossein Hosseinzadeh</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:B0B4CCC095102D257C6AC4B1641BC7142144138E</idno><date when="2008" year="2008">2008</date><idno type="doi">10.1002/ptr.2399</idno><idno type="url">https://api.istex.fr/ark:/67375/WNG-C88XF7ZV-W/fulltext.pdf</idno><idno type="wicri:Area/Istex/Corpus">002C81</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">002C81</idno><idno type="wicri:Area/Istex/Curation">002C81</idno><idno type="wicri:Area/Istex/Checkpoint">000881</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000881</idno><idno type="wicri:doubleKey">0951-418X:2008:Imanshahidi M:pharmacological:and:therapeutic</idno><idno type="wicri:Area/Main/Merge">001984</idno><idno type="wicri:Area/Main/Curation">001976</idno><idno type="wicri:Area/Main/Exploration">001976</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main">Pharmacological and therapeutic effects of Berberis vulgaris and its active constituent, berberine</title><author><name sortKey="Imanshahidi, Mohsen" sort="Imanshahidi, Mohsen" uniqKey="Imanshahidi M" first="Mohsen" last="Imanshahidi">Mohsen Imanshahidi</name><affiliation wicri:level="1"><country xml:lang="fr">Iran</country><wicri:regionArea>Pharmacodynamy and Toxicology Department, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad</wicri:regionArea><wicri:noRegion>Mashhad</wicri:noRegion></affiliation></author><author><name sortKey="Hosseinzadeh, Hossein" sort="Hosseinzadeh, Hossein" uniqKey="Hosseinzadeh H" first="Hossein" last="Hosseinzadeh">Hossein Hosseinzadeh</name><affiliation wicri:level="1"><country xml:lang="fr">Iran</country><wicri:regionArea>Pharmacodynamy and Toxicology Department, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad</wicri:regionArea><wicri:noRegion>Mashhad</wicri:noRegion></affiliation><affiliation wicri:level="1"><country wicri:rule="url">Iran</country></affiliation><affiliation wicri:level="1"><country xml:lang="fr" wicri:curation="lc">Iran</country><wicri:regionArea>Correspondence address: Pharmaceutical Research Center, Pharmacodynamy and Toxicology Department, School of Pharmacy, Mashhad University of Medical Sciences, PO Box 91775‐1365, Mashhad</wicri:regionArea><wicri:noRegion>Mashhad</wicri:noRegion></affiliation></author></analytic><monogr></monogr><series><title level="j" type="main">Phytotherapy Research</title><title level="j" type="alt">PHYTOTHERAPY RESEARCH</title><idno type="ISSN">0951-418X</idno><idno type="eISSN">1099-1573</idno><imprint><biblScope unit="vol">22</biblScope><biblScope unit="issue">8</biblScope><biblScope unit="page" from="999">999</biblScope><biblScope unit="page" to="1012">1012</biblScope><biblScope unit="page-count">14</biblScope><publisher>John Wiley & Sons, Ltd.</publisher><pubPlace>Chichester, UK</pubPlace><date type="published" when="2008-08">2008-08</date></imprint><idno type="ISSN">0951-418X</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0951-418X</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="Teeft" xml:lang="en"><term>Alkaloid</term><term>Antimicrobial</term><term>Antiplatelet</term><term>Aortic</term><term>Aureus</term><term>Barberry</term><term>Berberine</term><term>Berberine chloride</term><term>Berberis</term><term>Berberis vulgaris</term><term>Bilirubin</term><term>Cardiac</term><term>Coli</term><term>Congestive heart failure</term><term>Copyright</term><term>Cyclosporine</term><term>Decoction</term><term>Escherichia</term><term>Hepatic</term><term>Hosseinzadeh</term><term>Huang</term><term>Hypotensive</term><term>Imanshahidi</term><term>Inhibitory effect</term><term>Inhibitory effects</term><term>Iran</term><term>Isoquinoline</term><term>Isoquinoline alkaloids</term><term>Ivanovska</term><term>John wiley sons</term><term>Mrna</term><term>Napalert</term><term>Peng</term><term>Pharm</term><term>Pharmacol</term><term>Pharmacological effects</term><term>Philipov</term><term>Phytother</term><term>Platelet</term><term>Protective effects</term><term>Rabbani</term><term>Receptor</term><term>Toxicity</term><term>Ventricular</term><term>Vulgaris</term><term>Wang</term><term>Zeng</term><term>Zhou</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Barberry (Berberis vulgaris L. family Berberidaceae) is well known in Iran and various parts of this plant including its root, bark, leaf and fruit have been used as folk medicine. The two decades of research has demonstrated different pharmacological and therapeutic effects of B. vulgaris and its isoquinoline alkaloids (particularly berberine). Studies carried out on the chemical composition of the plant show that the most important constituents of this plant are isoquinoline alkaloids such as berberine, berbamine and palmatine. Berberine represents one of the most studied among the naturally occurring protoberberine alkaloids. In addition to B. vulgaris (barberry), berberine is present in many other plants and is used for the treatment of different diseases. This article reviews the traditional uses and pharmacological effects of total extract and the most active ingredient of B. vulgaris (berberine). Copyright © 2008 John Wiley & Sons, Ltd.</div></front></TEI><affiliations><list><country><li>Iran</li></country></list><tree><country name="Iran"><noRegion><name sortKey="Imanshahidi, Mohsen" sort="Imanshahidi, Mohsen" uniqKey="Imanshahidi M" first="Mohsen" last="Imanshahidi">Mohsen Imanshahidi</name></noRegion><name sortKey="Hosseinzadeh, Hossein" sort="Hosseinzadeh, Hossein" uniqKey="Hosseinzadeh H" first="Hossein" last="Hosseinzadeh">Hossein Hosseinzadeh</name><name sortKey="Hosseinzadeh, Hossein" sort="Hosseinzadeh, Hossein" uniqKey="Hosseinzadeh H" first="Hossein" last="Hosseinzadeh">Hossein Hosseinzadeh</name><name sortKey="Hosseinzadeh, Hossein" sort="Hosseinzadeh, Hossein" uniqKey="Hosseinzadeh H" first="Hossein" last="Hosseinzadeh">Hossein Hosseinzadeh</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001976 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001976 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= ChloroquineV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:B0B4CCC095102D257C6AC4B1641BC7142144138E
|texte= Pharmacological and therapeutic effects of Berberis vulgaris and its active constituent, berberine
}}
| This area was generated with Dilib version V0.6.33. |  |